Centrophenoxine

Centrophenoxine (also called Meclofenoxate, and formerly sold under the brand name Lucidril®) is a drug used to treat the symptoms of senile dementia and Alzheimer's Disease. It is a compound of two biochemicals: dimethylaminoethanol (DMAE) and parachlorophenoxyacetate (pCPA). DMAE is a natural substance, found especially in fish, and also produced in the human brain. pCPA is a synthetic compound that resembles to a variety of plant hormones called auxins.

Additional recommended knowledge

What is the Sensitivity of my Balance?

Don't let static charges disrupt your weighing accuracy

Weighing the right way

Like DMAE, it is a precursor to the neurotransmitter acetylcholine and may increase levels of this chemical in the CNS. It is reported to improve memory and general cognition.

It is also used off-label as a nootropic, often combined with a racetam drug such as piracetam. A typical nootropic dose is 250–500mg, 1–3 times per day.

Side Effects & Contraindications

Possible side effects may include nausea or mild dizziness. People with severely high blood pressure or convulsive disorders such as epilepsy should avoid Centrophenoxine. ^[1] Large doses may cause tight jaw clenching.

References

1. Centrophenoxine Page @ The American Academy of Anti-Aging Medicine